Related references
Note: Only part of the references are listed.Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial
Keith S. Kaye et al.
CLINICAL INFECTIOUS DISEASES (2019)
Current clinical use of intravenous fosfomycin in ICU patients in two European countries
C. Putensen et al.
INFECTION (2019)
Ceftolozane-tazobactam and Fosfomycin for rescue treatment of otogenous meningitis caused by XDR Pseudomonas aeruginosa: Case report and review of the literature
Antonella Frattari et al.
IDCASES (2018)
Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature
B. Grabein et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
D. van de Beek et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Flucloxacillin does not achieve therapeutic cerebrospinal fluid levels against meticillin-sensitive Staphylococcus aureus in adults: A case report and review of the literature
Rusheng Chew et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase
Wenjuan Wei et al.
JOURNAL OF CHEMOTHERAPY (2016)
Fosfomycin: Resurgence of an old companion
Sangeeta Sastry et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study
Ute Blassmann et al.
CRITICAL CARE (2016)
Bacterial meningitis: an update of new treatment options
Roland Nau et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Fosfomycin versu meropenem in bacteraemic urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
Clara Rosso-Fernandez et al.
BMJ OPEN (2015)
In Vitro Activity of Fosfomycin Alone and in Combination with Ceftriaxone or Azithromycin against Clinical Neisseria gonorrhoeae Isolates
Christoph Hauser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Favorable outcome in cerebral abscesses caused by Citrobacter koseri in a newborn infant
Sarah Algubaisi et al.
IDCASES (2015)
Efficacy and Safety of Fosfomycin Plus Imipenem as Rescue Therapy for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Multicenter Clinical Trial
Ana del Rio et al.
CLINICAL INFECTIOUS DISEASES (2014)
In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus
Yu Xu-hong et al.
JOURNAL OF ANTIBIOTICS (2014)
Successful Treatment of a Patient with Ventriculoperitoneal Shunt-Associated Meningitis Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae
Yu-Chen Tseng et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Fosfomycin Synergy In Vitro with Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents
Jillian L. Descourouez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa
Denissani Aparecida Ferrari dos Santos Lima et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
G. Samonis et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin
Guillaume Mellon et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Lemierre syndrome complicating multiple brain abscesses caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae cured by fosfomycin and meropenem combination therapy
Wen-Sen Lee et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2012)
Fosfomycin: Efficacy against infections caused by multidrug-resistant bacteria
Aurelien Dinh et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Human Tuberculous Meningitis Caused by Mycobacterium caprae
Niels Hansen et al.
CASE REPORTS IN NEUROLOGY (2012)
Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods
Ching-Lan Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
A. Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2010)
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin
M. E. Falagas et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Update in the diagnosis and management of central nervous system infections
Wendy C. Ziai et al.
NEUROLOGIC CLINICS (2008)
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid:: results of population pharmacokinetic modelling and Monte Carlo simulation
T. P. Lodise et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antibiotic abscess penetration: Fosfomycin levels measured in pus and simulated concentration-time profiles
R Sauermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children
A Faye et al.
ARCHIVES DE PEDIATRIE (2005)
The importance of bactericidal drugs: Future directions in infectious disease
RW Finberg et al.
CLINICAL INFECTIOUS DISEASES (2004)
Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis
B Pfausler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
In vitro activity of fosfomycin in combination with various antistaphylococcal substances
K Grif et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Share Paper
